Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sumitomo Dainippon Pharma Co. Ltd.
DescriptionPeptide vaccine derived from Wilms' tumor gene 1 (WT1) protein
Molecular Target Wilms tumor 1 (WT1)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today